Beacon Trust’s AstraZeneca AZN Stock Holding History

Beacon Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$205K	Buy	+3,500	New	+$204K	0.03%	175
2016 Q4	–	Sell	-3,500	Closed	-$230K	–	179
2016 Q3	$230K	Hold	3,500	–	–	0.04%	161
2016 Q2	$211K	Buy	+3,500	New	+$203K	0.04%	169
2016 Q1	–	Sell	-3,500	Closed	-$238K	–	181
2015 Q4	$238K	Sell	3,500 -1,270	-27%	-$83.3K	0.04%	160
2015 Q3	$304K	Hold	4,770	–	–	0.05%	149
2015 Q2	$304K	Hold	4,770	–	–	0.05%	156
2015 Q1	$327K	Hold	4,770	–	–	0.05%	167
2014 Q4	$335K	Hold	4,770	–	–	0.05%	164
2014 Q3	$341K	Sell	4,770 -25	-0.5%	-$1.83K	0.06%	148
2014 Q2	$356K	Sell	4,795 -162	-3%	-$11.7K	0.06%	144
2014 Q1	$321K	Sell	4,957 -59	-1%	-$3.81K	0.05%	146
2013 Q4	$297K	Buy	5,016 +221	+5%	+$12K	0.05%	150
2013 Q3	$249K	Hold	4,795	–	–	0.05%	153
2013 Q2	$227K	Buy	+4,795	New	+$244K	0.04%	160

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Beacon Trust's AZN Position: Q1 2017 in Review

Beacon Trust opened a new position in AstraZeneca (AZN) in Q1 2017: 3,500 shares worth $205K. The stake represents 0.03% of the portfolio and ranks #175 among its holdings. This is a return to the name: Beacon Trust previously reported a position in AZN as recently as Q3 2016.

Beacon Trust first reported a position in AZN in Q2 2013 and has held it in 14 quarters since. The position peaked at $356K in Q2 2014. 460 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

Beacon Trust held 3,500 shares of AstraZeneca worth $205K as of Q1 2017.
AstraZeneca was a new Beacon Trust position in Q1 2017.
AstraZeneca made up 0.03% of Beacon Trust's portfolio in Q1 2017, its #175 holding.
Beacon Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 14 quarters since.
Beacon Trust's AstraZeneca position peaked at $356K in Q2 2014.
460 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.